BC-N-102

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBC-N-102
Drug Alias NameBC-N102BC-N-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHR-positive breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical University
China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University
Inactive CompaniesN/A
Active IndicationsHR-positive breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A